Bio-Rad CFX Opus Deepwell Dx Real-Time PCR System

Bio-Rad Laboratories has launched the CFX Opus Deepwell Dx Real-Time PCR System — a real-time PCR system listed with the US FDA for in vitro diagnostic (IVD) testing and developed in accordance with the European Union’s regulations for in vitro diagnostic medical devices (EU 2017/746). Bio-Rad will continue to seek regulatory approvals for additional global markets in the coming months.

The system is designed to offer precise quantification with flexibility for reactions up to 125 µL in a 96-well format for quantitative PCR (qPCR) diagnostic assays. It is also available in a 96- and 384-well reaction block format.

All systems in the range are open platforms that can multiplex up to five targets to enable efficient IVD assay development and diagnostic testing. The systems offer easy-to-use desktop management and analysis software with integrated security features for electronic signature, audit and user control.